Skip Navigation

Systemwide Research

Systemwide Research


Research has been a fundamental and critical aspect of Geisinger’s mission since the health center was founded early last century. In addition to the research being conducted in Geisinger’s dedicated research centers, system-wide clinical departments and service-line faculty are engaged in numerous investigative projects. Geisinger’s departments of Cardiology, Rheumatology, and Vascular Surgery and both pediatric and adult oncology departments are particularly active in both investigator-initiated research and third-party trials. Efforts in oncology are directly facilitated by Geisinger’s membership in many adult oncology cooperative groups. These groups are sponsored by the National Cancer Institute and by the Community Clinical Oncology Program (CCOP) award from the National Institutes of Health, as well as by a similar grant from Pennsylvania’s Department of Health. 

Geisinger’s clinical departments and service lines include practice clinic sites across central and northeastern PA and its 12 specialty clinics, such as Knapper Pediatrics and the Woodbine Outpatient Surgery Center. Geisinger’s three hospitals - Danville, South Wilkes-Barre, and Wyoming Valley - and Geisinger’s nationally recognized addiction treatment program, Marworth, include 726 physicians and 257 residents and fellows.

This site provides information about research being conducted within Geisinger’s 27 service lines and clinical departments. Though the list of publications for each department is not exhaustive, it does demonstrate the types of projects being undertaken and the significant role of research throughout Geisinger’s entire health system.

Rheumatology research selected for video release

A Geisinger study on hydroxychloquine's (a popular rheumatoid arthritis medication) ability to significantly improve lipid profiles in rheumatoid arthritis patients was chosen for inclusion in a UK website of the National American College of Rheumatology meeting highlights. The website includes 30 prominent studies - from a field of thousands. Study co-author and rheumatology fellow Stephanie Morris, DO, is shown here on an excerpt from the interview.